Evidence map›Paper›PMID 34163362›Full record

ArticleFrontiers in pharmacology2021

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice.

Urszula Tyrankiewicz, Mariola Olkowicz, Piotr Berkowicz, Magdalena Jablonska, Ryszard T Smolenski, Jerzy A Zoladz, Stefan Chlopicki

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Urszula TyrankiewiczJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Mariola OlkowiczDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Piotr BerkowiczJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Magdalena JablonskaDepartment of Magnetic Resonance Imaging, Institute of Nuclear Physics, Polish Academy of Sciences, Krakow, Poland.
Ryszard T SmolenskiDepartment of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Jerzy A ZoladzDepartment of Muscle Physiology, Faculty of Rehabilitation, University School of Physical Education, Krakow, Poland.
Stefan ChlopickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Jagiellonian University · PLGdańsk Medical University · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLUniversity School of Physical Education in Kraków · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiotensin-converting enzyme inhibition (ACE-I) and physical activity favorably modulate the ACE/ACE-2 balance. However, it is not clear whether physical activity and ACE-I could synergistically modulate ACE/ACE-2 balance in the course of heart failure (HF). Here, we studied the effects of combined spontaneous physical activity and ACE-I-based treatment on angiotensin (Ang) pattern and cardiac function in a mouse model of HF (Tgαq*44). Tgαq*44 mice with advanced HF (at the age of 12 months) were running spontaneously in a running wheel (exercise training group, ExT) and/or were treated with ACE inhibitor (ACE-I, perindopril, 10 mg/kg) for 2 months. Angiotensin profile was characterized by an LC-MS/MS-based method. The cardiac performance was assessed

Indexed as

angiotensin-converting enzyme inhibitionangiotensinsheart failuremicespontaneous physical activity

Identifiers

PMID34163362
PMCPMC8215444
OpenAlexW3169753242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.